Top

Journal of Neurology

Published in:

01-07-2010 | Letter to the editors

Charcot–Marie–Tooth disease type 2D with a novel glycyl-tRNA synthetase gene (GARS) mutation

Authors: Ayumi Hamaguchi, Chiho Ishida, Kazuo Iwasa, Akiko Abe, Masahito Yamada

Published in: Journal of Neurology | Issue 7/2010

Excerpt

Sirs, …

Antonellis A, Ellsworth RE, Sambuughin N et al (2003) Glycyl tRNA synthetase mutations in Charcot–Marie–Tooth disease type 2D and distal spinal muscular atrophy type V. Am J Hum Genet 72:1293–1299CrossRefPubMed

Abe A, Hayasaka K (2009) The GARS gene is rarely mutated in Japanese patients with Charcot–Marie–Tooth neuropathy. J Hum Genet 54:310–312CrossRefPubMed

Freist W, Logan DT, Gauss DH (1996) Glycyl-tRNA synthetase. Biol Chem Hoppe Seyler 377:343–356PubMed

Nangle LA, Zhang W, Xie W, Yang XL, Schimmel P (2007) Charcot–Marie–Tooth disease-associated mutant tRNA synthetases linked to altered dimer interface and neurite distribution defect. Proc Natl Acad Sci USA 104:11239–11244CrossRefPubMed

Xie W, Nangle LA, Zhang W, Schimmel P, Yang XL (2007) Long-range structural effects of a Charcot–Marie–Tooth disease-causing mutation in human glycyl-tRNA synthetase. Proc Natl Acad Sci USA 104:9976–9981CrossRefPubMed

Del Bo R, Locatelli F, Corti S et al (2006) Coexistence of CMT-2D and distal SMA-V phenotypes in an Italian family with a GARS gene mutation. Neurology 66:752–754CrossRefPubMed

Dubourg O, Azzedine H, Yaou RB et al (2006) The G526R glycyl-tRNA synthetase gene mutation in distal hereditary motor neuropathy type V. Neurology 66:1721–1726CrossRefPubMed

James PA, Cader MZ, Muntoni F, Childs AM, Crow YJ, Talbot K (2006) Severe childhood SMA and axonal CMT due to anticodon binding domain mutations in the GARS gene. Neurology 67:1710–1712CrossRefPubMed

Rohkamm B, Reilly MM, Lochmuller H et al (2007) Further evidence for genetic heterogeneity of distal HMN type V, CMT2 with predominant hand involvement and Silver syndrome. J Neurol Sci 263:100–106CrossRefPubMed

10.

Sivakumar K, Kyriakides T, Puls I et al (2005) Phenotypic spectrum of disorders associated with glycyl-tRNA synthetase mutations. Brain 128:2304–2314CrossRefPubMed

11.

Schellens RL, van Veen BK, Gabreëls-Festen AA, Notermans SL, van ‘t Hof MA, Stegeman DF (1993) A statistical approach to fiber diameter distribution in human sural nerve. Muscle Nerve 16:1342–1350CrossRefPubMed

Title: Charcot–Marie–Tooth disease type 2D with a novel glycyl-tRNA synthetase gene (GARS) mutation
Authors: Ayumi Hamaguchi
Chiho Ishida
Kazuo Iwasa
Akiko Abe
Masahito Yamada
Publication date: 01-07-2010
Publisher: Springer-Verlag
Published in: Journal of Neurology / Issue 7/2010
Print ISSN: 0340-5354
Electronic ISSN: 1432-1459
DOI: https://doi.org/10.1007/s00415-010-5491-x

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Charcot–Marie–Tooth disease type 2D with a novel glycyl-tRNA synthetase gene (GARS) mutation

Excerpt

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 7/2010

Erratum to: Absence of aquaporin-4 antibodies in patients with idiopathic intracranial hypertension

Does clinical rapid eye movement behavior disorder predict worse outcomes in Parkinson’s disease?

Erratum to: Oligoclonal bands and MRI in clinically isolated syndromes: predicting conversion time to multiple sclerosis

Communication in conversation in stroke patients

Requests for euthanasia: origin of suffering in ALS, heart failure, and cancer patients

Remote cerebral hematomas in patients treated with intravenous rt-PA